The goal of this work was to test the hypothesis that subnormal serum IgA levels would be associated with increased risk of future exacerbations in COPD, examining participants from the large, well-characterized Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS). Here, CD79A is linked to chronic obstructive pulmonary disease.